Magnitude of sympathovagal imbalance and its correlation with inflammatory response and oxidative stress in pregnant women at risk of pregnancy induced hypertension: a cross-sectional study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242930Keywords:
Gestational hypertension, High blood pressure, High risk pregnancy, Hypertensive disorder of pregnancyAbstract
Background: Pregnancy-induced hypertension (PIH) is a common complication of pregnancy but it’s genesis isn’t known. It is proposed to be due to an excessive inflammatory response in the mother secondary to placental or maternal factors. The study aimed to measure the magnitude of sympathovagal imbalance (SVI) and to evaluate the role that oxidative stress and the inflammatory response play in the development of sympathovagal imbalance in pregnant mothers with risk factors of pregnancy-induced hypertension.
Methods: A cross-sectional study was carried out among pregnant women with at least one risk factor for PIH and age-matched pregnant women without risk factors for PIH as controls from March 2023 to February 2024 in a tertiary care hospital in Pondicherry. The intergroup differences in the mean between the two groups were compared using the Mann Whitney test and the Student's T-test.
Results: Short-term heart rate variability was significantly higher among cases while time domain analysis didn’t show significance. Total Cholesterol (TC), Triglycerides (TG), Very Low-Density Lipoprotein (VLDL) and Low-Density Lipoprotein (LDL) were significantly higher among the cases and High-Density Lipoprotein (HDL) was low in cases compared to controls. There is a strong correlation of Low Frequency to High Frequency (LF-HF) ratio with Tumor Necrosis Factor-alpha (TNF-α) and high sensitivity (hs-CRP) in patients with risk factors of PIH.
Conclusions: Pregnant women at risk of pregnancy-induced hypertension showed increased inflammatory response, oxidative stress and dyslipidaemia. Hence, conducting sessions for stress management not only during pregnancy but also in the pre-pregnancy period can alleviate sympathetic dysfunction.
References
Sengodan SS, N S. Prevalence of hypertensive disorders of pregnancy and its maternal outcome in a tertiary care hospital, Salem, Tamil Nadu, India. Int J Reprod Contracept Obstet Gynecol. 2020;9(1):236-9.
Gudeta TA, Regassa TM. Pregnancy induced hypertension and associated factors among women attending delivery service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia. Ethiop J Health Sci. 2019;29(1):831-40.
Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019;8(10):1625.
Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499-506.
Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393-8.
Fisher JP, Young CN, Fadel PJ. Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci Basic Clin. 2009;148(1-2):5-15.
Moors S, Staaks KJJ, Westerhuis MEMH, Dekker LRC, Verdurmen KMJ, Oei SG, et al. Heart rate variability in hypertensive pregnancy disorders: A systematic review. Pregnancy Hypertens. 2020;20:56-68.
Malik M. Heart Rate Variability Standards of Measurement, Physiological Interpretation, and Clinical Use: Task Force of The European Society of Cardiology and the North American Society for Pacing and Electrophysiology. Ann Noninv Elec. 1996;1(2):151.
Yousif D, Bellos I, Penzlin AI, Hijazi MM, Illigens BMW, Pinter A, et al. Autonomic dysfunction in preeclampsia: a systematic review. Front Neurol. 2019;10.
GK P. Textbook of medical physiology. 2nd ed. New Delhi: Ahuja Publishing House; 2011:573-9.
Charkoudian N, Rabbitts JA. Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin Proc. 2009;84(9):822-30.
ScienceDirect Topics. Heart Muscle Oxygen Consumption - an overview. Available at: https://www.sciencedirect.com/topics/immunology-and-microbiology/heart-muscle-oxygen-consumption. Accessed 14 June 2024.
Adenekan MA, Oluwole AA, Olorunfemi G, Sekumade AI, Ajepe AA, Okunade KS. Maternal tumour necrosis factor-alpha levels in preeclamptic pregnancies in Lagos, South-West Nigeria. Pregnancy Hypertens. 2022;30:198-203.
Straznicky NE, Lambert GW, Lambert EA. Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Curr Opin Lipidol. 2010;21(1):21-30.
Sogani S, Jain S. Comparison of the level of lipid peroxidative marker and antioxidants between preeclamptic and normotensive pregnant women. Int J Clin Biochem Res. 2023;8(2):87-91.
Tain YL, Hsu CN. Oxidative stress-induced hypertension of developmental origins: preventive aspects of antioxidant therapy. Antioxidants. 2022;11(3):511.
Taylor BD, Ness RB, Olsen J, Hougaard DM, Skogstrand K, Roberts JM, et al. Serum leptin measured in early pregnancy is higher in women with preeclampsia compared to normotensive pregnant women. Hypertension. 2015;65(3):594-9.
Veiga EC de A, Korkes HA, Salomão KB, Cavalli RC. Association of LEPTIN and other inflammatory markers with preeclampsia: A systematic review. Front Pharmacol. 2022;13:966400.
Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159(6):1404-16.
Ahotupa M. Lipid oxidation products and the risk of cardiovascular diseases: role of lipoprotein transport. Antioxidants. 2024;13(5):512.
Munno M, Mallia A, Greco A, Modafferi G, Banfi C, Eligini S. Radical oxygen species, oxidized low-density lipoproteins, and lectin-like oxidized low-density lipoprotein receptor 1: a vicious circle in atherosclerotic process. Antioxidants. 2024;13(5):583.
Bhati P, Alam R, Moiz JA, Hussain ME. Subclinical inflammation and endothelial dysfunction are linked to cardiac autonomic neuropathy in type 2 diabetes. J Diabetes Metab Disord. 2019;18(2):419-28.
Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013;4(1):4-18.
